SciBac scibac.com


SciBac wants to combat antibiotic-resistant infections with smart colonies of healthy bacteria. The company aims to target Clostridium difficile (C. diff), a potentially fatal and often recurring gastrointestinal infection. Using "rEvolutionary" live biotherapeutics, it stops colonization, neutralizes toxins, and directly kills C. diff organisms. The company is also developing a single-strain inhaled biotherapeutic for patients with cystic fibrosis. That therapy aims to break down the problemati...Show all

SciBac wants to combat antibiotic-resistant infections with smart colonies of healthy bacteria. The company aims to target Clostridium difficile (C. diff), a potentially fatal and often recurring gastrointestinal infection. Using "rEvolutionary" live...Show all

Company (Alive / Active)

Phone:

Fax:

521 Cottonwood Dr
Suite 131
Milpitas, 95035
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
SciBac $0M Apr 13, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related SciBac Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Method for producing chimeric microbial hybrids Jul 15, 2016 Sep 19, 2017 Patent
Method for producing chimeric microbial hybrids Aug 14, 2017 Application